Company Introduction

Company introduction

R&D Pipeline
Daewoong
Pharmaceutical Co., Ltd.

Daewoong Pharmaceutical is the pharmaceutical

company with the No. 1 sales of prescription
drugs in the Korean market.
Established in 1945 in Seoul, South Korea, Daewoong Pharmaceutical
offers high-quality and innovative pharmaceutical products and is one
of the top market leaders in Korea.
For over 60 years, Daewoong Pharmaceutical has been providing better
health for people through its total dedication to healthcare. Daewoong
has built strong core competency for new drug development to meet
diverse medical needs and enhance human life.
Building on our core strength, Daewoong Pharmaceutical has involved
in becoming a global healthcare group by operating our foreign branch-
es in SE Asia and by collaborating with global partners. We have an
inspiring mission to become a top 50 global healthcare company which
contributes to improving the quality of life for people worldwide.
The reinforcement of the R&D capacities through the establishment of
R&D center in the USA, China and India.
Daewoong Lifescience Research Institute has been focused on devel-
oping new chemical entities, biologics, incrementally modified drugs
CEO and high-value added APIs. Daewoong has also been studying to find
Lee, Jong Wook
solutions for the unmet therapeutic needs of neuropathic pain disease,
Location
Alzheimer’s disease as well as other innovative programs like anticancer
163-3, Samsung-dong,
Kangnam-gu, Seoul, gene therapy. Daewoong is operating several overseas offices in China,
Korea Vietnam, Indonesia, Thailand, Philippines, USA, and India and has R&D
Homepage centers in China, India and America.
www.daewoong.com

26 27